Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/29490

Type
Article
Copyright
Restricted access
Embargo date
2028-08-30
Collections
Share

Statistics
Metadata
Show full item record

TELAPREVIR-BASED THERAPY IN PATIENTS COINFECTED WITH CHRONIC HEPATITIS C VIRUS INFECTION AND HIV: INSIGHT STUDY
Montes, Maria Luisa et al. | Date Issued: 2016
Author
Montes, Maria Luisa
Nelson, Mark
Girard, Pierre-Marie
Sasadeusz, Joe
Horban, Andrzej
Grinsztejn, Beatriz
Zakharova, Natalia
Rivero, Antonio
Durant, Jacques
Ortega-Gonzalez, Enrique
Lathouwers, Erkki
Janssen, Katrien
Ouwerkerk-Mahadevan, Sivi
Witek, James
González-García, Juan
Affilliation
Servicio de Medicina Interna, Unidad de VIH, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Chelsea and Westminster Hospital, London, UK.
Hôpital St Antoine and INSERM, UMR S1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Warsaw Medical University and Hospital of Infectious Diseases, Warsaw, Poland.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Saint-Petersburg AIDS Center, St Petersburg, Russian Federation.
Unidad de Enfermedades Infecciosas, Hospital Universitario Reina Sofía/IMIBIC, Córdoba, Spain.
Infectious Diseases Department, L'Archet Hospital, University of Nice, Nice, France
Unidad de Enfermedades Infecciosas, Hospital General Universitario, Valencia, Spain.
Janssen Infectious Diseases BVBA, Beerse, Belgium.
Janssen Infectious Diseases BVBA, Beerse, Belgium.
Janssen Infectious Diseases BVBA, Beerse, Belgium.
Janssen Research & Development LLC, Titusville, NJ, USA
Servicio de Medicina Interna, Unidad de VIH, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Abstract
INSIGHT (ClinicalTrials.gov NCT01513941) evaluated the efficacy, safety and pharmacokinetics of telaprevir-based therapy and specific antiretroviral agents in hepatitis C virus genotype 1 (HCV-1)/HIV-1-coinfected patients.
Citation
MONTES, M. L. et al. Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study. Journal of Antimicrobial Chemotherapy, v. 71, n. 1, p. 244-250, 2016
DOI
10.1093/jac/dkv323
ISSN
0305-7453